Fibromyalgia in rheumatoid arthritis: features of pain syndrome, impact on disease activity and quality of life of patients
https://doi.org/10.14412/1996-7012-2022-1-32-37
Abstract
The prevalence of fibromyalgia (FM) in the general population is 2–8%, and among patients with rheumatic diseases it is 2–3 times higher. The presence of comorbid FM significantly affects the course of rheumatoid arthritis (RA).
Objective: to assess the effect of FM on RA activity indicators, features of pain syndrome, and quality of life (QoL) of patients.
Patients and methods. The study included patients with a confirmed diagnosis of RA. RA activity was assessed by the DAS28 index. FM was diagnosed according to the 2016 ACR criteria using the FM Diagnostic Questionnaire (FSQ). Patients also completed the central sensitization questionnaires – CS (CSI) and PainDETECT (PD). Pain intensity at rest was assessed using a visual analog scale (VAS, 10 cm), QoL was assessed using the FIQR and EQ-5D questionnaires.
Results and discussion. 55 patients with RA were examined. FM was diagnosed in 24 of them (43.6%). RA activity in the presence and absence of FM (FM+ and FM- respectively) was high: the DAS28 index in the FM+ group averaged 4.58 points, and in the FM- group it was 5.14 points (p=0.227). The median pain intensity according to VAS in the FM+ and FM- groups was 6.5 and 4.0 cm, respectively (p=0.017). Symptoms of CS were more common in patients with FM than in patients without FM (p=0.004). The median score on the PD questionnaire in the FM+ and FM- groups reached 17.5 and 11.0 points, respectively (p=0.015). Patients with FM had lower QoL scores both in EQ-5D (p=0.037) and FIQR (p<0.001).
Conclusion. FM is a serious burden for RA patients. The pain syndrome in the presence of FM is of greater intensity and prevalence, accompanied by neuropathic descriptors, which significantly worsens the quality of life in patients with RA.
About the Authors
N. A. Melikova
Department of neurological diseases, I.M. Sechenov First Moscow Medical State University (Sechenov University); V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Najabat Alievna Melikova
8, Trubetskaya street, Build. 2, Moscow 119991
34A, Kashirskoe Shosse, Moscow 115522
E. G. Filatova
Department of neurological diseases, I.M. Sechenov First Moscow Medical State University (Sechenov University)
Russian Federation
Russian Federation
8, Trubetskaya street, Build. 2, Moscow 119991
A. M. Lila
V.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology, Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
2/1, Barrikadnaya street, building 1, Moscow 125993
References
1. Walker J. Fibromyalgia: clinical features, diagnosis and management. Nurs Stand. 2016 Sep 28;31(5):51-63. doi: 10.7748/ns.2016.e10550.
2. Borchers AT, Gershwin ME. Fibromyalgia: A Critical and Comprehensive Review. Clin Rev Allergy Immunol. 2015 Oct;49(2):100-51. doi: 10.1007/s12016-015-8509-4.
3. Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep. 2016 Apr; 20(4):25. doi: 10.1007/s11916-016-0556-x.
4. Toussaint L, Vincent A, McAllister SJ, Whipple M. Intra- and Inter-Patient Symptom Variability in Fibromyalgia: Results of a 90-Day Assessment. Musculoskeletal Care. 2015 Jun;13(2):93-100. doi: 10.1002/msc.1090.
5. Lichtenstein A, Tiosano S, Amital H. The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol. 2018 Jan; 30(1):94-100. doi: 10.1097/BOR.0000000000000464.
6. Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and metaanalysis. Rheumatol Int. 2017 Sep;37(9):1527-39. doi: 10.1007/s00296-017-3725-2.
7. Karateev AE, Nasonov EL. Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs. Nauchno-Prakticheskaya Revmatologiya. 2019; 57(2):197-209 (In Russ.).
8. Häuser W, Jung E, Erbslцh-Mцller B, et al. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One. 2012;7(5):e37504. doi: 10.1371/journal.pone.0037504.
9. Bennett RM, Friend R, Jones KD, et al. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4): R120. doi: 10.1186/ar2783.
10. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-29. doi: 10.1016/j.semarthrit.2016.08.012.
11. Kang JH, An M, Choi SE, et al. Performance of the revised 2016 fibromyalgia diagnostic criteria in Korean patients with fibromyalgia. Int J Rheum Dis. 2019 Sep;22(9): 1734-40. doi: 10.1111/1756-185X.13661.
12. Häuser W, Ablin J, Fitzcharles MA, et al. Fibromyalgia. Nat Rev Dis Primers. 2015 Aug 13;1:15022. doi: 10.1038/nrdp.2015.22.
13. Gist AC, Guymer EK, Eades LE, et al. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018 Mar;21(3):639-46. doi: 10.1111/1756-185X.13055.
14. El-Rabbat MS, Mahmoud NK, Gheita TA. Clinical significance of fibromyalgia syndrome in different rheumatic diseases: Relation to disease activity and quality of life. Reumatol Clin (Engl Ed). 2018 Sep-Oct;14(5):285-9. doi: 10.1016/j.reuma.2017.02.008.
15. Salaffi F, Gerardi MC, Atzeni F, et al. The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int. 2017 Dec; 37(12):2035-42. doi: 10.1007/s00296-017-3792-4.
16. Mülkoglu C, Ayhan FF. The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study. Mod Rheumatol. 2021 Jul;31(4):827-833. doi: 10.1080/14397595.2020.1823069.
17. Joharatnam N, McWilliams DF, Wilson D, et al. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther. 2015 Jan 20;17(1): 11. doi: 10.1186/s13075-015-0525-5.
18. Salaffi F, Di Carlo M, Carotti M, Sarzi-Puttini P. The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia. Rheumatol Int. 2018 Oct;38(10): 1911-8. doi: 10.1007/s00296-018-4096-z.
19. Filatova ES, Erdes SF, Filatova EG. Central regulation of pain in patients with joint disease and approaches to therapy. Terapevticheskii arkhiv. 2016;88(12):159-64 (In Russ.).
20. Bailly F, Cantagrel A, Bertin P, et al. Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic. RMD Open. 2020 Sep;6(2):e001326. doi: 10.1136/rmdopen-2020-001326.
21. Shraim MA, Masse-Alarie H, Hall LM, Hodges PW. Systematic Review and Synthesis of Mechanism-based Classification Systems for Pain Experienced in the Musculoskeletal System. Clin J Pain. 2020 Oct;36(10):793-812. doi: 10.1097/AJP.0000000000000860.
22. Fitzcharles MA, Cohen SP, Clauw DJ, et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021 May 29;397(10289):2098-110. doi: 10.1016/S0140-6736(21)00392-5.
23. Filatova ES, Lila AM, Parfenov VA. Neuropathic pain in rheumatoid arthritis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(5):60-5. (In Russ.). doi: 10.14412/2074-2711-2020-5-60-65
24. Bucourt E, Martaillй V, Goupille P, et al. A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjцgren's Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping Strategies. Pain Med. 2021 Feb 23;22(2):372-81. doi: 10.1093/pm/pnz255.
25. Moyano S, Scolnik M, Vergara F, et al. Evaluation of Learned Helplessness, Perceived Self-efficacy, and Functional Capacity in Patients With Fibromyalgia and Rheumatoid Arthritis. J Clin Rheumatol. 2019 Mar;25(2): 65-8. doi: 10.1097/RHU.0000000000000769.
26. Ovayolu N, Ovayolu O, Karadag G. Healthrelated quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy ndividuals. Clin Rheumatol. 2011 May; 30(5):655-64. doi: 10.1007/s10067-010-1604-2.
Review
For citations:
Melikova NA, Filatova EG, Lila AM. Fibromyalgia in rheumatoid arthritis: features of pain syndrome, impact on disease activity and quality of life of patients. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2022;16(1):32-37. (In Russ.) https://doi.org/10.14412/1996-7012-2022-1-32-37
Views:
2071
Email this article 